HopeStage
Back to all studies
CompletedNCT00833547

Eszopiclone and sleep-related learning in schizophrenia

About this titleRead the official source — NCT00833547
Medication studyAges 18–45United States
The study in practice

Understand this study

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 45 years. Other eligibility criteria applied.

Listed locations
BostonSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateSeptember 2006
Recruitment status
Completed
Enrollment listed in the registry
25
Sponsor
Massachusetts General Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Locations
United States
Age range
From 18 Years to 45 Years
Official registry ID
NCT00833547
Official title
Show the full official title

Effects of Eszopiclone on Sleep-dependent Learning in Schizophrenia

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Boston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including eszopiclone and placebo.

Who was this study for?

This study was for people with schizophrenia. Listed age limits: 18 years to 45 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies